Internship Report On Management Accounting Practice at Beximco Pharmaceuticals LTD: A Review of Costing Function

Internship Report
On
Management Accounting Practice
At Beximco Pharmaceuticals Ltd:
A Review Of Costing Function
‘Management Accounting Practice At Beximco Pharmaceuticals
Ltd: A Review Of Costing Function’
by
Syeda Afrina Sarwar

ID: 07304063
BRAC Business School
BRAC University, Bangladesh

August 2011
‘Management Accounting Practice At Beximco Pharmaceuticals
Ltd: A Review Of Costing Function’
Submitted By:
Syeda Afrina Sarwar

ID: 07304063
Submitted To:
-------------------------------------------------
Ms. Rahnuma Ahmed
Lecturer
BRAC University, Bangladesh
August 2011
Letter of Transmittal
August 10, 2011
Ms. Rahnuma Ahmed
Lecturer
BRAC BUSINESS SCHOOL
BRAC University
66, Mohakhali
Dhaka-1212
Subject: Submission of Internship Report
Dear Madam,
I am submitting an internship report titled for ‘Management Accounting Practice At Beximco
Pharmaceuticals Ltd: A Review of Costing Function’ as a part of the requirement of the
course. Your guideline has been followed in every aspect of preparing this report. I have really
enjoyed working on this project and I hope that my work would meet the level of your
expectation.
Any query on this report is appreciated.
Thank You.
Sincerely,
Syeda Afrina Sarwar

ID:07304063
Acknowledgement
It’s difficult for me to thank all of those marvelous people who have contributed something of
them to this report. There are of course some very special people who cannot go without
mention.
At first I express my gratitude and indebtedness to our respected faculty, Ms. Rahnuma Ahmed
for her continuous guidance, important advice, encouragement and suggestion during the
preparation of the report. I thank of him for sparing her valuable time to read the report.
Then, I express my sincere gratitude to Mr. Jamal Ahmed Choudhury, Executive Director, in
BPL for his guidance, constants supervision and constructive suggestions. Without his help this
report might not have been a comprehensive one. I also like to thank Mr. Kamal Uddin
Ahamed Deputy Manager, Accounts and Finance. Without his help I cannot prepare my report
so informative. I have bothered him so many times in connection with my works, both during
and after normal working hours.
Finally I am grateful to all the cooperative staffs of the Accounts Department of BPL.
Executive summary
The report is based on Management Accounting Practice At Beximco Pharmaceuticals Ltd: A
Review Of Costing Function’. The purpose of this report is to understand how the cost
elements of materials are being determined and to identify the factors which affect the costing
procedure. .
Beximco is part of the Beximco Group of Companies. The history of pharmaceutical

business of the company dates back to the early 70s, when it started to import market and
distribute medicines from world renowned companies like Upjohn Inc. of USA and Bayer AG of
Germany. Since the very beginning, the company was highly successful in generating
increased demand for its products which eventually justified local production. Accordingly a
pharmaceutical manufacturing facility was designed and constructed in 1980 under the
technical supervision of Upjohn Inc. of USA, to manufacture their products under license.
Products made under license of Bayer AG of Germany followed. BPL has now grown to become
one of Bangladesh's leading pharmaceutical companies, supplying more than 10% of country's
total medicine need. Today Beximco Pharma manufactures and markets its own branded
generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both
national and international markets.
Management Accounting is concerned with the provisions and use of accounting information to
managers within organizations, to provide them with the basis in making informed business
decisions that would allow them to be better equipped in their management and control
functions. Listed below are the primary tasks performed by management accountants generated
by different cost accounting tools that are as follows: Variance Analysis, Rate & Volume
Analysis, Product Profitability, Cost Analysis & Cost Benefit Analysis, Cost-Volume-Profit
Analysis, Life cycle cost analysis, Capital Budgeting, Strategic Planning Strategic Management
Advise, Internal Financial Presentation and Communication, Sales and Financial Forecasting &
Annual Budgeting, Cost Allocation and Resource Allocation and Utilization.
Basically, Cost accounting information -- and, more generally, accounting information -- has
three basic roles in organizations:
1. Financial reporting,
2. Operational control and improvement, and
3. Decision making and planning.
Costing procedure of a Pharmaceuticals company is very important and vast thing. It needs
to update in a regular basis. Moreover, all Pharmaceuticals firms try to keep this information
secret in this competitive market. Like all other pharmaceuticals company Beximco follows
standard costing method for medicine productions. The unit price of each medicine is
calculated by batch wise. About 70-80 percent of all manufacturing materials are purchased
from the foreign county. Only 20- 25 percent of the total are collected from the local markets.
Beximco purchases more than 600 items of raw materials and more than 3,000 packaging
materials for manufacturing of medicine.
Major reasons for which the price of the materials is affected are-LC opening charge, Demurrage
charge, Inflation, Exchange rate changes and C & F commissions, etc. Yearly increment of
salary is one of the major issues of labor rate increasing. Beximco Pharma provides salary
increment every year. Therefore, the cost of direct labor is increased. The reasons for increasing
the overhead cost are- Markets rates of utilities like gas, electricity and water, Repair and the
maintenance costs, Insurance premiums etc. are increased due to reducing the life of the
machines. Product development costs are increased due to highly competition in the medicine
markets both home and abroad.
Pharmaceuticals sector of Bangladesh like all other industries is going to face new
challenges. Rising price of materials in the international market and higher domestic
inflation is going to be a big issue. Besides, competition in the local pharmaceuticals market
is expected to intensity further. Beximco has to be aware of those issues to become a market
leader in the industry. Though the sales revenue has decreased in the last year due to various
reasons, it has the ability to regain its glorious pasts and advanced further .
Table of Content
Descriptions PAGE
No.
CHAPTER ONE: INTRODUCTION
1.1 Origin Of The Report
1.2 Objectives
1.3 Scope
1.4 Methodology
1.5 Organization of the study
1.6 Limitations
CHAPTER TWO: PART ONE- OVERVIEW OF THE COMPANY
2.1.1 History Background Of BPL
2.1.2 Vision Of BPL
2.1.3 Mission Of BPL
2.1.4 Board And Management
2.1.5 Organizational Structure Of BPL
2.1.6 Products
2.1.7 International Market
2.1.8 Corporate Strategies
2.1.9 Corporate Social Responsibility
CHAPTER TWO: PART TWO- DESCRIPTION OF JOB
2.2.1 Specific Responsibilities Of The Job
2.2.2 Different Aspects Of Job Performance
CHAPTER THREE: PART ONE-
INTRODUCTION OF MANAGEMENT ACCOUNTING
3.1.1 Definition of Management Accounting
3.1.2 Management Accounting Techniques
3.1.3 Management Accounting Functions
3.1.4 Relationship Among Cost Accounting, Financial
Accounting And Management Accounting
3.1.5 Difference Among Cost Accounting, Financial
Accounting And Management Accounting
3.1.6 Management Accounting Information in Decision
Making
3.1.7 Management Accounting Information in Corporate
Reporting
CHAPTER THREE: PART TWO-
MATERIALS - CONTROLLING AND COSTING
3.2 Materials Management
3.2.1 Procedure of Material Acquisition
3.2.2 Materials Acquisition Cost
3.2.3 Product Costing And Cost Allocations
3.2.4 Contemporary cost accounting methods and
techniques used by Beximco Pharma
3.2.5 Factors That Affects The Costing Procedure At
Beximco Pharma
CHAPTER FOUR: FINDINGS
CHAPTER FIVE: RECOMENDATIONS
CHAPTER FIVE: CONCLUSION
Bibliography
CHAPTER ONE: INTRODUCTION
1
1. Introduction Part
1.1 Origin of the report:
The report is originated to make a study on the costing procedure and the internal control
system of Beximco Pharmaceuticals Limited as a part of the fulfillment of internship
program required for the completion of BBA program of BRAC University. As the part of
BBA curriculum this project is assigned to me by Jamal Ahmed Choudhury Executive
Director, Accounts & Finance, Beximco Pharmaceuticals Ltd and approved by the academic
Supervisor Ms. Rahnuma Ahmed, lecturer of BRAC University, Department BBA,
1.2 Objective of the report:

The objectives of the report are as follows:-
Major objective of this report is to show what are the major functions or the chain works of
Costing and Budgeting section of Accounts and Finance Departments at Beximco
Pharmaceuticals Ltd. After reading this report learners will know the following issues:
• To have an idea about the background of Beximco pharmaceuticals Ltd.

• To get an introduction about the organizational structure & how co-ordination among
different set of activities is made..
• To set a general idea about operating procedures and functions of Accounts and Finance
Department of BPL
• To explore the specific costing procedure followed by the Beximco

Pharmaceuticals Limited
• To get idea about LC & Local purchase documentation & payment procedures;
• To identify the factors which affect the costing procedure
• To relate the theoretical learning with the real life situation.
• How the chain works are completing.
2
1.3 Scope of the report:
Costing procedure of a Pharmaceuticals company is very important and vast thing. It needs
to update in a regular basis. Moreover, all Pharmaceuticals firms try to keep this information
secret in this competitive market. So the study was basically tried to identify the costing
procedure followed by BPL and what are the factors concerned with this procedure. The
study was also tried to identify and analyze the various expenses incurred by the BPL in
an accounting year. A comparative study was conducted with the same aspects of Square
Pharmaceuticals Limited.
1.4 Methodology of the report:
The following methodology was followed throughout the study .The study is based on both
primary as well as secondary data.
Data regarding the organization profile collected in the following ways:
Primary Source
7 Careful observation of various activities of related section of that particular department,
7 Discussions with the officials of Accounting and Finance department.
Secondary Source
7 Organizational Brochures/ Annual Reports.

7 Online information.
7 Different BPL publications.
7 Other relevant written materials.
Data Collection Techniques:
7 Some of the primary data were collected by observing others doing their jobs.
7 Much of the primary data were collected by the informal interviewing of the company
officials.
7 Most of the secondary data were collected by the review and study of relevant reports and
documents.
3
1.5 Organization of the study
The report is divided into five parts. The first part is the introductory chapter. The second part
covers organizational part (a brief overview of Beximco Pharmaceutical Limited). The Third part
deals with report part. The fourth part includes overall findings with concluding remarks. The
last part provides Bibliography and annexure.
1.6 Limitations:
Although I received co-operation from the concerned officials, they were not always able to give
me much time, as they were busy with their works. Time is an important issue in Report writing.
As I have been given a specific deadline for submission, observation and learning all the
functions of costing and budgeting within 3 months was really tough. Besides, all the comments
made, conclusions reached and suggestions for possible improvement provided are purely based
on my level of understanding, knowledge and my way of interpreting a particular statement.
Because of the lack of information, I have to make some assumptions that may cause few errors
or personal mistakes in the report. In spite of all these limitations, I have tried to put the best
effort as far as was possible.
4
CHAPTER TWO: PART ONE-

OVERVIEW OF THE COMPANY
5
2.1.1 Historical background:
Beximco Pharmaceutical Ltd. is a leading edge pharmaceutical company based in Dhaka,

Bangladesh and is a member of the Beximco Group. The history of pharmaceutical business of
the company dates back to the early 70s, when it started to import market and distribute
medicines from world renowned companies like Upjohn Inc. of USA and Bayer AG of Germany.
Since the very beginning, the company was highly successful in generating increased demand for
its products which eventually justified local production. It completed its registration in 1976 and
started its operation in 1980 by manufacturing and marketing licensee products of Bayer AG of
Germany and Upjohn Inc. of USA. After its initial years of struggle it broke ground with the
launching of its own products in 1983. In 1985 BPL was listed in Dhaka Stock Exchange (DSE)
as a Public Limited Company. The journey continued and barrier after barrier were crossed,
challenges were faced and overcome to transform BPL into what it is at present. Now it has
grown to become nation's one of the leading pharmaceutical companies, supplying more than
10% of the country's total medicine need. In the process, it was enlisted in Chittagong and
London Stock Exchange. Today Beximco manufactures and markets its own `branded generics'
for almost all diseases from AIDS to cancer, from infection to asthma, from hypertension to
diabetes for both national and international markets.
It manufactures a range of dosage forms including tablets, capsules, dry syrup, powder, cream,
ointment, suppositories, large volume intravenous fluids, metered dose inhalers etc. in several
world-class manufacturing plants, ensuring high quality standards complying with the World
Health Organization (WHO) approved current Good Manufacturing Practices (cGMP). Beximco
also contract manufactures for major international brands of leading multinational companies.
Beximco has a strong market focus and is anticipating continued future growth by leveraging
business capabilities and developing superior product brands and markets. In particular it is very
interested in developing a strong export market in USA and Europe. To meet the future demand
it has invested over US 50 million dollar to build a new state-of-the-art manufacturing plant,
confirming to USFDA and UK MHRA standards. This new plant will also offer contract-
manufacturing facility to leading pharmaceutical companies, especially from Europe and US.
6
2.1.2 Vision:
“If there is one characteristic that has typified the BEXIMCO approach, it is the Vision to be the
best of our nature and human resource; a vision to establish our group and country as a respected
and valued regional presence.”
2.1.3 Mission:
“Each of our activities must benefit and add value to the common wealth of our society. We
firmly believe that, in the final analysis we are accountable to each of the constituents with
whom we interact, namely: our employees, our customers, our business associates, our fellow
citizens and our shareholders.”
2.1.4 Organizational Structure of BPL
7
2.1.5 Board and Management

Beximco Pharmaceuticals Ltd. is managed by the Board of Directors, an Executive Committee
and a Management Committee. Board of Directors is responsible for the corporate governance.
It consists of eleven members including the Chairman, A S F Rahman and the Vice Chairman,
Salman F Rahman. The five-member Executive Committee is headed by Mr. Osman Kaiser
Chowdhury who is also a member of the Board of Directors. The Executive Committee is
accountable for both operational and financial performance of the company. This committee is
also responsible for budget approval, policy adoption or changes, new project review,
compliance audit etc. The Management Committee comprises of ten eleven-notch professionals
who are one of the bests in Bangladesh in their own fields. This committee is leaded by Mr.
Nazmul Hasan, Chief Executive Officer (CEO) who is responsible for the overall management of
the business. This committee reviews and manages day-to-day business operation and
recommends strategy options to the Executive Committee.
The Board of Directors:-

Chairman A S F Rahman
Vice Chairman Salman F Rahman
Managing Director Nazmul Hassan
Iqbal Ahmed Director

Mohammad Abul Qasem Director
Osman Kaiser Chowdhury Director
Abu Bakar Siddiqur Rahman Director
Dr. Farida Huq Director
Advocate Ahsanul Karim Director
Dr. Abdul Alim Khan Independent Director
Company Secretary Md. Asad Ullah, FCS
The Executive Committee:-
Osman Kaiser Chowdhury Member of the Board of Directors
Nazmul Hassan Managing Director
Ali Nawaz Chief Financial Officer
Afsar Uddin Ahmed Director, Commercial
The Management Committee:-
Osman Kaiser Chowdhury Member of the Board of Directors
Nazmul Hassan MP Managing Director
Ali Nawaz Chief Financial Officer
Afsar Uddin Ahmed Director, Commercial
8
Rabbur Reza Director, Marketing

Lutfur Rahman Director, Manufacturing
Shamim Momtaz Director, Manufacturing
Zakaria Seraj Chowdhury Director, International Marketing
Mohd. Tahir Siddique Executive Director, Quality
A R M Zahidur Rahman Executive Director, Production
Jamal Ahmed Choudhury Executive Director, Accounts & Finance
2.1.6 Products:
The company’s diverse product portfolio encompasses a wide variety of therapeutic categories,
including antibiotics, analgesics, respiratory, cardiovascular, central nervous system,
dermatology, gastrointestinal etc. BPL currently produces 235 generics in 426 strengths and
dosage forms and many of the company’s brands are consistently occupying leading positions in
their respective therapeutic categories.
In 2010 Beximco Pharma introduced 27 new generics in a total of 34 presentations, which

include seven ophthalmic drops, three HFA asthma inhalers and also drugs in categories such as,
three cardiovascular, two multivitamins, two musculoskeletal, two anti-infective, and one anti-
diabetic, among others.
The three HFA-based inhalers which were launched for the first time in Bangladesh in 2010.
Also introduce for first time into the market was a formulation of Paracetamol 665 mg. Napa
Extend.
Baximco Pharma’s Growth prospects remain excellent with key blockbuster products such as
Napa and Neoceptin-R in its portfolio.
In 2010 Napa and Neoceptin R ranked 2nd and 4th respectively on the national “Top Five” list.
More over ten of BPL’s brands have annual sales in excess of BDT 100 million each.
9
Block Buster product:
Napa Highest selling drug in Bangladesh

pharmaceutical market in terms of unit.
Neoceptin-R Highest selling drug in Bangladesh
pharmaceutical market in terms of value.
Bextrum/Bextrum Gold Emerged as the most admired and highest
selling nutritional supplement in Bangladesh
Market in just one year.
Amdocal Highest selling cardiovascular drug in BD in
terms of value.
Tofen Highest selling oral anti-asthma drug in BD in
terms of value.
Azmasol Highest selling mastered dose inhaler in
Bangladesh in terms of value.
Source: Annual Report 2010 of BPL
2.1.7 International Market:

Beximco Pharma continues to explore export opportunities and to reinforce its footprint on a
global scale, which currently covers five different continents. Alongside the continuous
endeavour to strengthen the position in existing markets, BPL attempts to achieve dynamic
growth worldwide.
Beximco Pharma commenced its international operations with the export of API to Hong Kong
in 1992 and formulation products to Russia in 1993. The company has received the ‘National
Export Trophy’ (Gold) for an impressive three times. Since then, BPL has taken greater strides
over the years to increase its footprints in international markets.
In 2010, BPL successfully ventured into several new countries including South Africa (via
contract manufacturing) and Netherlands Antilles, and registered 45 products in overseas
markets. The company achieved export revenues of Tk 330.54 million, up 21.47% over 2009.
The current expansion of this overseas portfolio includes prioritizing and directing marketing
operations to focus more on highly regulated markets such as the European Union (EU), USA,
Australia and GCC member countries for value added generics.
10
As of 2010 Beximco Pharma has 322 products registered in Asia, 91 in Africa, five in Central
and Latin America, and 22 in Middle East, while we are actively taking measures to register our
products in attractive branded generic markets such as the CIS states and the EU countries.
BPL’s products are highly trusted for their quality by physicians and consumers at home and
abroad. With this acclamation BPL is supplying different formulations from its portfolio to
renowned hospitals and institutions including Raffles Hospital, Healthway Medical Group & K.
K. Women and Children Hospital in Singapore; Asthma Drug Facility (ADF) in France;
CENABAST in Chile; and MEDS and Kenyatta National Hospital in Kenya. BPL is constantly
investing in its state-of-the-art manufacturing facilities to significantly expand its capabilities to
meet the regulatory requirements of developed countries. BPL has pursued approvals from
different drug regulatory authorities, e.g. TGA (Australia), GCC (Gulf Council), ANVISA
(Brazil) and INVIMA (Colombia), which highlights BPL’s credentials as it explores new
opportunities in the export arena.
In brief, BPL is now involved in the following national markets:
Iran South Korea Cambodia
Malaysia Taiwan Philippines
Hong Kong Russia Somalia
Ukraine Georgia Sri Lanka
Pakistan Myanmar Kenya
Singapore Nepal Mozambique
Yemen Vietnam
Table 3: Export Countries of BPL
2.1.8Corporate Strategies:
Quality:
The BPL believes that being in the business which deals with human health makes us more
responsible. This sense of responsibility compels BPL to keep the highest standards of its
products. Through these products we seek to deliver clear health benefits and higher values to the
patients. With this in mind BPL has commissioned state-of-the-art manufacturing facilities with
innovative new technologies. Beximco Pharma use the most modern equipment for quality
control and stringent quality assurance procedure and the manufacturing process conforms
strictly to the current Good Manufacturing Practices.
11
Research & Development:

From its inception till date, BPL’s research & development (R&D) capabilities continue to be
one of the essential core strengths for leading the industry in both formulation R&D and API
R&D. BPL’s formulation R&D capability is proven not only by the consistent quality of its
products but also by its ability to introduce hi-tech, specialized niche products and dosage forms.
The reverse engineering capability of BPL’s R&D team has enabled us to introduce innovative
new products to serve the ailing people at home and a broad. The reverse engineering capability
of the R&D team and the drive towards new product development and innovation are central to
building a proprietary research operation within Beximco Pharma. In formulation R&D, the
company focuses principally on developing new formulations, predominantly through reverse
engineering techniques and on simplifying manufacturing processes and improving cost
efficiency. Over the years, the R&D team has successfully formulated different high-tech
formulations like multi-layer tablets, long acting formulations, dispersible tablets etc. Beximco
Pharma also the pioneer in introducing anti-retroviral drugs and anti-cancer drugs in Bangladesh.
Recently, with long experience in MDI formulations, BOL’s R&D team has successfully
developed a range of CFC-free HFA MDIs. The R&D team consists of qualified scientists with
background in pharmaceutical sciences and allied areas and has a strong network with global
companies and scientific community with similar expertise.
2.1.9 Corporate Social responsibility:
Corporate social responsibility (CSR), also known as corporate responsibility, corporate

citizenship, responsible business, sustainable responsible business (SRB), or corporate social
performance, is a form of corporate self-regulation integrated into a business model. Ideally,
CSR policy would function as a built-in, self-regulating mechanism whereby business would
monitor and ensure its adherence to law, ethical standards, and international norms. Business
would embrace responsibility for the impact of their activities on the environment, consumers,
employees, communities, stakeholders and all other members of the public sphere. Furthermore,
business would proactively promote the public interest by encouraging community growth and
development, and voluntarily eliminating practices that harm the public sphere, regardless of
12
legality. Essentially, CSR is the deliberate inclusion of public interest into corporate decision-
making, and the honoring of a triple bottom line: People, Planet and Profit.
Corporate Social Responsibility (CSR) is an integral part of Beximco Pharmaceuticals business

strategy. Some of the CSR activities undertaken by the company are showing as follows:-
¾ As a first Bangladeshi Pharma company BPL introducing anti-retroviral medicines for
HIV/AIDS treatment, medicine to combat the virus of bird flu and an oral anti-smoking
drug to help chronic smokers quit smoking.
¾ Food and Medicine donation during different natural disasters.
¾ Sponsoring, organizing & participating many cultural and sports events like Corporate
Cricket League, SAAf Football Championship, Inter-School Handball tournament, Open
air concert etc.
¾ Publishing posters-banners-festoons, arranging rallies-seminars-conference etc. on AIDS,
Diabetes, Smoking, Cancer, Asthma, Birds Flu etc.
¾ Beximco Pharmaceuticals Ltd. manufactures CFC-free Metered Dose Inhalers among the
few pharmaceuticals in the world.
13
CHAPTER TWO: PART TWO-

DESCRIPTION OF JOBS
14
2.2 Departments of Beximco Pharma
BPL operates its business through extensive departmentalization as needed for specified
effectiveness of the tasks. The business activities of BPL are directed, controlled and monitored
from the head office of Beximco Pharmaceuticals Ltd. Being a leading Pharmaceutical company
in the country it employs a good number of people in different departments to keeps its business
thriving. The following major departments coordinate the activities of BPL:
● Strategic Brand Management (SBM) department
● Planning department
● Procurement Department
● Sales department
● Training department
• Project management & Business Development Department

● International Marketing department
● MIS department
● Multimedia department
● Finance and Accounts department
● Human Resource Department (HRD)
● Market Research & Statistical Cell (MRC) department
2.2.1 Brief Description of Accounts & Finance department and others.

Accounts & Finance Department
The activities of the Accounts and finance department are carried over by talented and
adequate person. The functions of Accounts and Finance department are carried over five
sections. Actually proper control purpose, they subdivide their functions to the several
sections. The sections of Accounts and Finance department are as follows:
• IOC&BP
• Financial Accounts- Strategic Business Unit (SBU)
• Financial Accounts- Non- Strategic Business Unit
• Treasury
• Tax And Payroll
• Leasing And Legal Affairs
15
Hierarchy of Accounts and Finance Department:

Chief Financing
Officer
Executive
Director
Financial Financial Treasury Legal Tax and Pay IOC&BP

Accounts- SBU Accounts- Non (Manager affairs roll (Manager)
(Manager) SBU (Manager) ) (Manager) (Manager)
Accounts Accounts Accounts Accounts Accounts

Accounts officer
officer officer officer officer officer
Asst. Asst. Asst. Asst. Asst. Asst.

Accounts Accounts Accounts Accounts Accounts Accounts
officer officer officer officer officer officer
IOC&BP:
The extended form of IOC& BP is Industrial operation control & business planning. This section
does the Costing and Budgeting of BPL. Previously it was known as costing and budgeting
section but recently it has changed its name because of horizon of their work. Their work is not
bounded to the costing and budgeting functions only. They provide information to the planning,
marketing, purchasing and others departments for proper decision making. This section of
accounts and finance department does the reporting to the management. They prepare different
types of cost reports.
Activities of this department are as follows:
• Prepare cost sheet.
• Determine Manufacturing cost of a product.
• Allocate Overhead to the product.
• Determine Tender Cost sheet.
16
• Prepare different types of budgets such as Production budget, sales budget, cash budget,
master budget, purchase budget, Departmental budget etc.
• Prepare different types of report such as Scrap report, COGS report, Production report,
Product profitability report, biggest loser report etc.
• Provide proper data to the planning department relating to costing.
• Help to control inventory.
• Identifies the cost centers.
• Does the inventory valuation. Etc.
Financial Accounts SBU:

The major function of this section is to prepare financial report. They prepare the financial report
of Beximco Pharma. There is a manager to monitoring the activities of this section. The major
activities of these sections are as follows:
• Preparation of Financial Report for External Reporting.
• Preparation of Monthly Financial Report.
• Preparation and publishing Quarterly Financial Report.
• Recording of Export Sales Earnings.
Financial Accounts Non SBU:

This section does the works of some supporting company of Beximco Pharma. These supporting
companies are as follows:
I. Shuktara Printing Ltd.: Shuktara Printing Ltd. supplies the printing materials to the
BPL. For leaflet and other printing materials are needed for drug are supplied by
Shuktara printing Ltd. though it is unable to supply all printing materials needed.
II. Bangladesh Antibiotic Industry Ltd.: Bangladesh Antibiotic Industry Ltd. (BAIL)
supplies antibiotic to the BPL. There is a manufacturing unit to Kaliakoir near to
Gazipur to produce antibiotic. There is a responsible person who prepares financial
reports and all recording related to BAIL. They also deal with the other pharmaceutical
company to supply materials. This services also known as toll services.
17
III. I & I services Ltd.: I&I services Ltd. provides distribution services to the BPL.
Through 19 depots they deliver drugs to the chemist. There is a central depot to control
all the depot and services.
IV. Pharmatek chemicals Ltd.: They provide Chemicals to the BPL. Pharmatek supplies
Napa raw materials to the BPL. There is a responsible person to control, reporting and
recording all transactions relating the Pharmateck chemicals Ltd.
Tax and Payroll:

The Tax and Payroll section of Accounts and Finance department deals with the taxation and
Payroll services to the company. The major activities are as follows:
• Salary disbursement to the employee.
• Salary loan to the employee.
• Provident fund related activities.
• Salary Tax.
• Income tax of the company.
Legal Affairs:
This section of Accounts and Finance deals with the legal issue of the BPL. The Major activities
of this section are as follows:
• Trade license of the company including the International selling.
• Value added tax related activities.
• Drag license related activities.
• New product Copyright.
• Trademark related activities.
• Boiler permission Renewal.
• Chemical Certificate related issue.
• Land related activities.
18
Treasury:
Treasury section deals with (i) cash at banks and (ii) bills. It also looks after the cash
planning and management. A review is made every week for this purpose. This department
controls and monitors cash flow positions. There is a responsible person for monitoring and
controlling activities of treasury sections.
2.2.2 Brief description of others departments:
Strategic Brand Management (SBM) Department

The activities of SBM are:
Market research
Selection of new product
Design and testing of product (DTP)
Sample store (logistics) management
Making strategy
Procurement Department
Previously it was known as Purchase department. The procurement department deals with
all the purchase of the organization such as:
• Pharmaceuticals raw materials.
• Packaging materials.
• Office equipments.
• Machinery's etc.
Planning & Inventory Control Department

The planning department is concerned with the production planning, raw material procurement
planning etc. After getting the sales forecast from the sales department, the planning department
goes through the current stock information of different raw materials. They decide when
materials will be procured.
19
Sales Department
Sales department is a marketing execution department. It supplies sales forecast to the

planning department. The activities and function of Sales department is very important.
The profit of the company is dependent on the sales. Sales department assigns selling
responsibility to the Medical Representative.
Human Resource Department
Major Activities of HR departments are as follows:
• Prepare Recruitment policy and procedure

• Placement of employees
• Human Resource Development planning
• Organizational structure review and modification
• Career planning
• Hiring and firing
• Job description preparation
• Conducting appraisal at the end of each year
• Maintaining and developing employees personal files
• Safety-security.
Project management & Business Development Department
Project management & Business Development Department began its operation from January
l, 2000. It is working on market development, both domestic and international. Major
functions are as follows:
• New product study
• New technology study
• Project feasibility study
20
MIS Department
The MIS Department takes care of total automation of BPL. It supports the hardware and
software network of the company and the factory.
Multimedia Department
Functions of the multimedia department are:

¾Web page designing.
¾Developing multimedia presentation for presentation programs.
¾Making videos of conferences, meeting etc.
¾Keeping the records of annual meeting and other meeting.
Medical Department
This department is a unique department in this industry as BPL established this first ever in
order to create easy relationship through using the professional linkage with the
doctors.
Training Department:
Training Department deals with the training activities of the company. BPL frequently arranges
training program for employees for their development of skills.
International Marketing:
International Marketing deals with the international marketing policy and procedures. Now day
by day export of BPL is growing. So this department is getting more emphasis.
21
CHAPTER THREE: PART ONE-

INTRODUCTION OF MANAGEMENT
ACCOUNTING
22
3.1.1 Definition of Management Accounting
Management Accounting is concerned with the provisions and use of accounting information to
managers within organizations, to provide them with the basis in making informed business
decisions that would allow them to be better equipped in their management and control
functions. Unlike financial accountancy information, management accounting information is
used within an organization “typically for decision-making” and is usually confidential and its
access available only to a select few.
According to the Chartered Institute of Management Accountants (CIMA), Management

Accounting is
" The process of identification, measurement, accumulation, analysis, preparation,
interpretation and communication of information used by management to plan, evaluate
and control within an entity and to assure appropriate use of and accountability for its
resources. Management accounting also comprises the preparation of financial reports for
non-management groups such as shareholders, creditors, regulatory agencies and tax
authorities" (CIMA Official Terminology).
The American Institute of Certified Public Accountants(AICPA) states that management

accounting as practice extends to the following three areas:
• Strategic Management—Advancing the role of the management accountant as a strategic
partner in the organization.
• Performance Management—Developing the practice of business decision-making and
managing the performance of the organization.
• Risk Management—Contributing to frameworks and practices for identifying, measuring,
managing and reporting risks to the achievement of the objectives of the organization.
The Institute of Certified Management Accountants(ICMA), states

"A management accountant applies his or her professional knowledge and skill in the
preparation and presentation of financial and other decision oriented information in such a way
23
as to assist management in the formulation of policies and in the planning and control of the
operation of the undertaking."
Management accounting practice helps an organization to survive in the competitive, ever-

changing world, because it provides an important competitive advantage for an organization that
guides managerial action, motivates behaviors, supports and creates the cultural values necessary
to achieve an organization’s strategic objectives.
3.1.2 Management Accounting Techniques
Management decisions are basically based on some measures/techniques traditionally designed

based on quantitative data. However, in recent past to cope with global business environment,
change in business, increase in competition and complexity of decision making some advanced
quantitative techniques like Activity – based Costing and Target Costing and some improved
programs like Just-in-Time (JIT), Total Quality Management (TQM), Process Reengineering
and Theory of Constraints (TOC) have been introduced for application. Now, both traditional
and advanced management accounting techniques are shown in the following chart.
Traditional Techniques Advanced Techniques

Financial Statement Analysis Activity-Based Costing
Fund Flow Analysis Target Costing
Cash Flow Analysis Just-in-Time (JIT)
Marginal Costing Total Quality Management (TQM)
Absorption Costing Process Reengineering
Differential Costing The Theory of Constraints(TOC)
Standard Costing
Opportunity Costing
Budgetary Control
Inter-firm Comparison
Cost-Volume-Profit Analysis
Management Reporting
Source: This chart has been developed by the author after consulting different text books on Management Accounting.
The above chart identifies the generally used management accounting techniques by classifying
them as to traditional and modern techniques.
24
3.1.3 Management Accounting Functions
Management accounting is a financial method that helps senior managers and department heads
analyze business performance. Management accounting functions relate primarily to budgeting
and cost analysis, internal financial reporting and monitoring of cost controls.
Actually, Management accounting may be said to include all activities connected with collecting,
processing, interpreting and presenting information to management. The management accounting
satisfies the various needs of management for arriving of appropriate business decisions. They
may be described as modification of data, analysis and interpretation of data, facilitating
management control, formulation of business budgets, use of qualitative information, and
satisfaction of informational needs of management.
Listed below are the primary tasks performed by management accountants generated by different
cost accounting tools. The degree of complexity relative to these activities is dependent on the
experience level and abilities –
Variance Analysis
Rate & Volume Analysis
Product Profitability
Cost Analysis & Cost Benefit Analysis
Cost-Volume-Profit Analysis
Life cycle cost analysis
Capital Budgeting
Strategic Planning Strategic Management Advise
Internal Financial Presentation and Communication
Sales and Financial Forecasting & Annual Budgeting
Cost Allocation
Resource Allocation and Utilization
25
3.1.4 Relationship between Cost Accounting, Financial Accounting,

Management Accounting and Financial Management
Cost Accounting is a branch of management accounting, which has been developed because
of the limitations of Financial Accounting from the point of view of management control
and internal reporting. Financial accounting performs admirably, the function of portraying
a true and fair overall picture of the results or activities carried on by an enterprise during a
period and its financial position at the end of the year. Also, on the basis of financial
accounting, effective control can be exercised on the property and assets of the enterprise to
ensure that they are not misused or misappropriated. To that extent financial accounting
helps to assess the overall progress of a concern, its strength and weaknesses by providing
the figures relating to several previous years. Data provided by Cost and Financial
Accounting is further used for the management of all processes associated with the efficient
acquisition and deployment of short, medium and long term financial resources. Such a
process of management is known as Financial Management. The objective of Financial
Management is to maximize the wealth of shareholders by taking effective Investment,
Financing and Dividend decisions. Investment decisions relate to the effective deployment
of scarce resources in terms of funds while the Financing decisions are concerned with
acquiring optimum finance for attaining financial objectives. On the other hand,
Management Accounting refers to managerial processes and technologies that are focused
on adding value to organizations by attaining the effective use of resources, in dynamic and
competitive contexts. Hence, Management Accounting is a distinctive form of resource
management which facilitates management’s ‘decision making’ by producing information
for managers within an organization.
3.1.5 Differences between Financial Accounting, Management

Accounting and Cost Accounting
FINANCIAL MANAGEMENT
ACCOUNTING ACCOUNTING
Primary Users External( Investors, Internal(Managers of business,
government authorities, employees)
creditors)
Purpose Of Information Help investors, creditors, and Help managers plan and control
26
others make investment, credit, business operations

and other decisions
Timelines Delayed or historical Current and future oriented
Restrictions GAAP FASB AND SEC GAAP does not apply, but
information should be restricted
to strategic and operational needs
Nature Of Information Objective, auditable, reliable, More subjective and judgmental,
consistent and precise valid, relevant and accurate
Scope Highly aggregated information Disaggregated information to
about the overall organisation support local decisions
Behavioural Implications Concern about adequacy of Concern about how reports will
disclosure affect employees behavior
Features Must be accurate and Usually approximate but relevant
timelyCompulsory under and flexibleExcept for few
company law Is an end in itself companies, it is not mandatory Is
a mean to the end
Segments Of Organisation It is primarily concerned with Segment reporting is the primary
reporting for the company as a emphasis.
whole.
FINANCIAL COST ACCOUNTING

ACCOUNTING
Objective It provides information about It provides information of
financial performance and ascertainments of costs to
financial position of control costs and for decision
the business. making about the costs.
Nature It classifies records, presents It classifies records, presents
and interprets transactions in and interprets in significant
terms of money. manner materials, labour and
overhead costs.
Recording Of Data It records historical data. It records and presents
estimated, budgeted data. It
makes use of both historical
costs and predetermined costs.
Users Of Information External users like Used by Internal management
shareholders, creditors, at different levels.
financial analysts, government
and its agencies, etc.
Analysis Of Costs And It shows profit/loss of the It provides details of costs and
Profits organization. profit of each product, process,
job,etc.
Time Period They are prepared for a definite They are prepared as and when
period, usually a year. required.
Presentation Of Information A set format is used for There are no set formats for
presenting financial presenting cost information.
information.
27
Cost accounting information -- and, more generally, accounting information -- has three basic
roles in organizations:
1. Financial reporting,
2. Operational control and improvement, and
3. Decision making and planning.
3.1.6 Cost Accounting Information in Decision Making:
Decision making is central to the management of an enterprise. The manager of a profit making
business has to decide on the manner of implementation of the objectives of the business, at least
one of which may well relate to allocating resources so as to maximize profit. All organizations,
whether in the private or the public sector, take decisions, which have financial implications.
Decisions will be about resources, which may be people, products, services, or long term and
short term investment. Decisions will also be about activities, including whether and how to
undertake them. Where the owners are different persons from the manager (for example,
shareholders of a company as separate persons from the directors), the managers may face a
decision where there is a potential conflict between their own interests and those of the owners.
In such a situation cost considerations may be evaluated in the wider context of the responsibility
of the managers to act in the best interests of the owners.
For making decision by using cost accounting information cost accountant usually follow some
specific models. They use different decision model for different courses of action. Management
accountants work with manager by analyzing and presenting relevant data to guide decisions.
For example, if any organization wants to reduce its existing manufacturing costs it must identify
the alternatives then it will analyze the alternatives by using only relevant data i.e., which can
influence the decisions.
3.1.7 Cost Accounting Information in Corporate Reporting:

The main purpose of cost accounting information is to help managers in decision making. Such
information is provided for the internal purpose only. There are some guided rules and
28
regulations about the information in the reports. According to IAS 1 (Presentation of Financial
Statements), paragraph 117,
“ An entity shall disclose in the summary of significant accounting policies:
(a) the measurement basis (or bases) used in preparing the financial statements, and
(b) the other accounting policies used that are relevant to an understanding of the
financial statements.”
It is important for an entity to inform users of the measurement basis or bases used in the
financial statements (for example, historical cost, current cost, net realizable value, fair value or
recoverable amount) because the basis on which an entity prepares the financial statements
significantly affects users’ analysis. When an entity uses more than one measurement basis in the
financial statements, for example when particular classes of assets are revalued, it is sufficient to
provide an indication of the categories of assets and liabilities to which each measurement basis
is applied. According to paragraph 125 of the same IAS,
“An entity shall disclose information about the assumptions it makes about the future,
and other major sources of estimation uncertainty at the end of the reporting period, that have a
significant risk of resulting in a material adjustment to the carrying amounts of assets
and liabilities within the next financial year. In respect of those assets and liabilities, the notes
shall include details of:
(a) their nature, and
(b) their carrying amount as at the end of the reporting period.
An entity presents the disclosures in paragraph 125 in a manner that helps users of financial
statements to understand the judgments that management makes about the future and about other
sources of estimation uncertainty. The nature and extent of the information provided vary
according to the nature of the assumption and other circumstances. Examples of the types of
disclosures an entity makes are:
(a) the nature of the assumption or other estimation uncertainty;
(b) the sensitivity of carrying amounts to the methods, assumptions and estimates
underlying their calculation, including the reasons for the sensitivity;
(c) the expected resolution of an uncertainty and the range of reasonably possible
outcomes within the next financial year in respect of the carrying amounts of the assets and
liabilities affected; and
29
(d) an explanation of changes made to past assumptions concerning those assets and
liabilities, if the uncertainty remains unresolved.
Other IFRSs require the disclosure of some of the assumptions that would otherwise be required
in accordance with paragraph 125. For example, IAS 37 requires disclosure, in specified
circumstances, of major assumptions concerning future events affecting classes of provisions.
IFRS 7 requires disclosure of significant assumptions the entity uses in estimating the fair values
of financial assets and financial liabilities that are carried at fair value. IAS 16requires disclosure
of significant assumptions that the entity uses in estimating the fair values of revalued items of
property, plant and equipment.
There are also some guidelines for reporting cost accounting information in IAS 2: Inventories.
The objective of this Standard is to prescribe the accounting treatment for inventories. A primary
issue in accounting for inventories is the amount of cost to be recognized as an asset and carried
forward until the related revenues are recognized. This Standard provides guidance on the
determination of cost and its subsequent recognition as an expense, including any write-down to
net realizable value. It also provides guidance on the cost formulas that are used to assign costs
to inventories.
30
CHAPTER THREE: PART TWO-

MATERIALS- CONTROLLING AND
COSTING
31
3.2 Materials Management
An effective materials management is essential in order to
(1) provide the best service to customers,
(2) produce at maximum efficiency, and
(3) manage inventories at predetermined levels to stabilize investments in inventories.
Successful materials management requires the development of a highly integrated and

coordinated system involves
• Sales Forecasting,
• Purchasing,
• Receiving,
• Storage,
• Production,
• Shipping,
• And Actual Sales.
The stages of material management may be enumerated as follows:
1. Procedures of materials acquisition

2. Cost of materials acquisition
3. Product costing and cost allocations
32
3.2.1 Materials Acquisition Procedure
Materials:
In Beximco Pharma Material is divided into two parts. These materials are the direct material for
the product. The classification of materials is as follows:
• Raw material.
• Packing material.
Before going to the report part, let’s have a look that what are the steps are involved in case of
purchasing raw and packing materials from local and abroad.
Both types of materials are purchased in two forms such as:
• Local purchase.
• Import of materials.
Local Purchase of Raw & Packing Materials:
The domestic purchase of raw material and Packing Material include following business
functions;
1. Processing purchase order
2. Receiving goods, material and services
3. Recognizing the liability
4. Processing and recording cash disbursement
Processing Purchase Order
The procedure begins with need recognition. The respective department identifies its need, gets
approval of the departmental head and with the approval an authorized person sends purchase
requisition to purchase department to initiate purchase. In case of raw or packing materials, the
planning department determines the quantity and timing of raw materials. This department
informs the purchase department when to buy materials.
33
When the purchase department got the requisition, it calls for quotation or tender. After receiving
the quotation or tender, supplier has been selected. The supplier may be local or international. If
the terms and conditions are in favor of both BPL and the selected supplier, the purchase order is
issued by the factory.
Receiving Material, Goods and Services
Generally the goods and services are received by the user department who has issued the
purchase requisition or in some cases by the authorized department. In case of Materials,
Materials are received by Quality Assurance Department (QAD) in the factory. After receiving
materials, MRR (Material Receiving Report) is issued for material and other than material
(goods) a GRR (Goods Receiving Report) is issued by receiving department to purchase
department.
Recognizing the liability
The purchase department compares the invoice/bill and MRR/ GRR/ QC with the purchase
order. If everything has been complied, the amount payable to supplier is approved by the
purchase department. There is a seal on the invoice named ‘Approved By’ with the signature of
purchase manager. It means the purchase department is satisfied with the information mentioned
in the bill.
Processing and Recording Check/ Cash Disbursement
After a certain period of time when the date becomes matured for the liability the payment is
made by BPL. The matured date has been calculated in the aged payable report for each vendor.
The mode of payment is usually per numbered check. In most cases the payment is made by
A/C payee only check. In some cases the payment may be made by cash or by bearer check or
paid in advance fully or partly.
The total process of Local Purchase has been presented briefly in below:
34
Requisition of respective
department
Tender / Quotation call
Issuing order
Receiving goods / Services by

factory/ Respective Department
Produce MRR / GRR
Receiving bills by purchase

department
Comply the bills with order, MRR /

GRR and approve
Sent bills to accounting

department
Accounts payable journal voucher/

provision voucher
Ready for payment
Accounts payable payment voucher
Issuing check
35
Import of Raw & Packing Materials:
Another source of raw and packing material is importing from overseas market. For this purpose,
purchase department must open a letter of credit at bank. It ensures the liquidity of foreign
supplier. After opening a letter of credit, Purchase department maintains a file where all the
related documents are kept separately for each LC and sends a copy of each document to the
Finance and Accounts department for further processing of information and to prepare the cost
sheet for the materials received against each LC. This file is called PC (pharmaceutical
consignment) file.
Three departments are involved in the entire materials procurement process.
They carry their own responsibilities in this regard. The departments are:
• Sales Department
• Planning & Inventory Control Department
• Procurement Department
The entire process looks like:
Sales Department Planning & Procurement Dept. Accounts

Sales Forecast Inventory control Pro forma Invoice PC, IV, BC Files
Dept. LC opening
Import Procurement
schedule
PC File (For Raw and Packing Materials and Also spare parts for pharmaceuticals machinery)
IV File (For Infusion Raw and Packing materials and also spare parts for Infusion machinery)
BC File (For Basic Chemical)
36
3.2.2 Materials Acquisition Cost
The cost of inventories comprises of expenditure incurred in the normal course of business in
bringing the inventories to their present location and condition. As a result, the costs of purchase
of inventories comprise the purchase price, import duties and other taxes (other than those
subsequently recoverable by the entity from the taxing authorities), and transport, handling and
other costs directly attributable to the acquisition of finished goods, materials and services.
Trade discounts, rebates and other similar items are deducted in determining the costs of
purchase. Actually, the focal point of this report is to put light on the cost of acquiring of raw and
packing material from local and foreign sources and related accounting conduct.
In case of imported materials,
L/C Costing:
The costing procedures of the imported material’s (Raw/Packing) Landed cost. To calculate the
unit cost of the imported material’s (Raw/ Packing) the term L/C costing is used.
L/C opening process:
The purchase dept. first collects a form of application for the opening of letter of credit
from a bank. An LCA form (in quintuplicate) is also collected. After filling up these forms,
they are submitted to the bank along with the pro forma invoice approved by the Block list
of Drug Administration and IMP form of Bangladesh Bank. The L/C margin (a certain
percentage of L/C amount), bank charges and commissions for opening the L/C, insurance
payment (if made at that time) etc. are also made. The insurance covers all risks from the
beginning of transit.
The Cost Sheet:
This is the most important report prepared on the import procurement process of raw materials.
Cost sheets are prepared for individual raw and packing material items, as well as spares and
capital machinery. Cost sheet is generated by the MAPICS software. It is the summary of entries
37
debited through the journal voucher of L/C. It is used for costing and pricing decisions. The cost
sheets include the following:
Through this cost sheet Beximco Pharma determines per unit landed cost of imported Raw
material and Packing material.
COST SHEET
Company Name: BEXIMCO PHARMA Shipment No:
Supplier Name: Date:
L/C No: Date: Exchange rate:
Invoice No: Date: CEP: Date:
PARTICULARS 1 2 Total
Material Name
MRR No
MRR Date:
Invoice Quantity
FC Cost/ Unit
Total FC Cost
L/C Margin
Opening Charge
Document Retirement
Duty, LCA, IDSC & others
C & F Commission
Insurance Premium
Miscellaneous Expenses
TOTAL COST
COST PER UNIT
38
Material Costing:
In case of imported materials some important formulas are as follows:
1. Assessable Value= Invoice Value X Exchange Rate X 1.01(Insurance) X 1.01 (Landed

Charge)
2. Customs Duty= Assessable Value X Customs Duty Rate (from Bill Of Entry)
3. Supplementary Duty= (Assessable Value + Customs Duty) X SD Rate (from Bill Of
Entry)
4. Pre-Shipment Inspection(PSI)= (Invoice Value X Exchange Rate) X PSI rate (from Bill
Of Entry)
5. Regulatory Duty= If CD% is greater than or equal to 25% then Assessable Value X 5%
Landed Cost = C&F Amount + CD amount +SD amount + PSI amount + RD amount + Others
expenses (C&F Commission, Insurance premium, Opening Charge, Misc. Exp.)
In case of Locally Procured Materials:
In case of locally procured materials the landed cost is Purchase order rate or Invoice rate.
39
Sample Material cost sheet:
BEXIMCO PHARMACEUTICALS LTD.

COSTING OF (PRODUCT NAME) Pack size:
PRODUCT CODE: Date:
Composition Materia Landed Per Tablet Per Pack
l code cost
Quantity Cost Quantity Cost
Raw Materials:
Active:
Raw material 1
Raw material 2
Excipients:
Raw material 1
Raw material 2
RAW MATERIAL COST
Packing Materials:
Primary Packing:
Packing material 1
Packing material 2
Secondary Packing:
Packing material 1
Packing material 2
PACKING MATERIAL COST
Total RM + PM cost
40
Managgement Acccounting Praactice
At Bexximco Pharrmaceuticalss Ltd:
A Review
R Of Costing
C Fun
nction
3.2.33 Producct costingg and cosst allocations
Productt Costs:
Product costs includ

de all costss involved in
i acquiringg or makingg a product. In the casse of
manufacttured goodss, these costts consist of direct matterials, direcct labor, annd manufacturing
overheadd. Product co
osts attach to units of prroduct as thhe goods are purchased or manufacttured,
and they remain attacched as the goods
g go intto inventoryy awaiting saale. Product costs are iniitially
assigned to an inven
ntory accounnt on the ballance sheet. When the goods
g are soold, the costts are
released from inventtory as expeenses (typicaally called cost
c of goodds sold) and matched aggainst
sales reveenue. Producct cost is alsso called Maanufacturing costs.
nents of Product cost:

Compon
• Direct
D Materiials.
• Direct
D Labor..
• Manufacturin
M ng Overheadd.
Figuure 4: Produuct costs Claassifications in BPL

Direct Materials:
M
Direct Materials
M are those mateerials that beecome an inntegral part of the finisshed productt and
whose coosts can be conveniently
c traced to the finished prroduct.
In BPL direct
d materiaal classificattion is as folllows:
1. Raw
R Materiall:
¾ Activee
¾ Excip pients
2. Packing Mateerial:
¾ Primaary Packing
¾ Secon ndary Packinng
41
A Review
R Of Costing
C Fun
nction
Direct Labor:
L
Direct labbor consists of labor cossts that can be

b easily traced to indiviidual units of
o product. Direct
D
labor is sometimes called touchh labor, sincce direct labbor workers typically toouch the prooduct
while it is being maade. In BPL
L direct labor includes labor cost of worker which
w is dirrectly
traceablee.
Manufaccturing Oveerhead:
Manufacturing costs that cannott be traced directly

d to specific
s unitss produced is manufacturing
overheadd. Manufactu
uring overheead includes indirect matterials, indirrect labor annd costs relatted to
the manuufacturing faacility.
Graphicaal presentatio
on of manufa
facturing oveerhead whichh is used in BPL
B is as folllows:
Figure
F 5: Manufacturing
M g overhead classification
c n in BPL
Classifiication of Manufactu
M uring costss in other way:
Prime coost:
Prime coost is the sum
m of direct materials
m costt and direct labor
l cost.
Conversion Cost:
Conversiion cost is the

t sum of direct laborr cost and manufacturin
m ng overheadd cost. The term
conversioon is used to
o describe direct
d labor and
a manufaccturing overrhead becausse these costts are
incurred to convert materials
m intoo the finishedd product.
42
A Review
R Of Costing
C Fun
nction
In Bexim
mco Pharmacceuticals Lim
mited they usse this conversion cost concept
c to report
r the Coost of
Goods Soold and to prrepare cost sheet.
s
Fig
gure 6: Classsification off manufacturring cost in other
o ways.
Non maanufacturiing Costs:

Non mannufacturing costs
c are ofteen divided inn BPL into tw
wo categoriees:
• Selling expen nses.
• Administrativ
A ve expenses.
Selling Expenses:
E
Selling costs
c includee all costs thhat are incurred to secuure customerr orders andd get the finished
product to
t the custom
mer.
Exampless: Advertisin
ng, salary annd allowancces, rent expenses, printiing and statiionery, telepphone
& postagge, market reesearch & new
n product, sample exppense, sales travel, depreeciation, dellivery
commissiion, export freight,
f insurrance, C&F expense etc..
Adminisstrative Exp
penses:
Administtrative costss include all executive, organization

o nal and clerical costs asssociated witth the
general management
m t of the organnization rathher than withh manufacturring or sellinng.
Exampless: Executivves compennsation, donnation & subscriptionn, auditor’ss remuneraation,
entertainnment, teleph
hone and poostage, AGM
M expenses, company seecretarial exxpenses, leggal &
consultanncy fee etc.
43
A Review
R Of Costing
C Fun
nction
Productt cost flow
w:
Product cost
c flow is the
t flow of costs
c in a maanufacturingg company. Beximco
B Phaarma follow
ws this
product cost
c flow. Th
he graphical presentationn of product cost flow iss as follows:
Fiigure 7: Product cost floow of BPL.

Factoryy Overhead
d:
Factory Overhead
O iss generally defined
d as inndirect laborr, indirect material
m and all other faactory
expensess that canno
ot convenienntly be idenntified with nor chargedd directly too specific joob or
products or final co
ost objectivees. Other terrms used foor factory overhead
o aree factory buurden,
manufactturing expen
nse, manufaacturing overhead, factoory expense,, and indirecct manufacturing
cost.
To determ
mine cost off production these expennses are to be
b apportioneed to various departmennt and
then to thhe cost centeer or cost uniits. The proccedures are as
a follows:
• C
Classification
n of Overheaad.
• C
Collection off Overhead.
• A
Apportionme
ent of Overheead.
44
• Absorption of overhead by production units.
Classification:
Overhead can be classified into three ways. These are as follows:
1. Function wise: Production overhead, Administrative overhead and Selling and

Distribution overhead.
2. Element wise: Indirect material, indirect labor and indirect expenses.
3. Behavior wise: Variable, fixed and semi- variable.
In Beximco Pharma they use function wise classifications.
Codification:
In order to make effective analysis and control of the expenses each of overhead is classified into
groups. Two major benefits of these methods are:
• Clearly defined.
• Cover every circumstance.
Three methods for these are as follows:
1. Mnemonic Method.
2. Numerical Method.
3. Decimal Method.
Mnemonic Method: Under this method letter symbols are used to denote expenses heading as
aids to memory. For example we can explain it in following ways:
• AD for Administration.
• RE for Repair.
• MA for Maintenance. Etc.
Numerical Method: Where numerical codes are employed each departments or cost center is
also given a code number. This number is put on all documents used for collection of overheads.
For example we can explain it in following ways:
• 120080-0-200 Stores.
45
• 120080-0-100 Entertainment.
• 120080-0-300 Boiler house.
• 120080-0-301 Stoker’s wages
• 120080-0-302 Coke
• 120080-0-303 Water. etc.
Decimal Method: This is also numerical coding method. Under this method the items falling
under each groups, however, represented by decimals. For example:
1200.101 Indirect materials.

1200.102 Indirect labor.
1200.103 Entertainment.
1200.104 Repairs & Maintenance. Etc.
Beximco Pharma’s practices:
In Beximo Pharma they use the Numerical method for recoding items. They have different types
of code for every item. Through the numerical method they try to ensure proper control.
Collection of Overhead:
The collection of overhead information in Beximco Pharma is as follows:
• Store requisitions.
• Time cards/ Job cards.
• Invoice or purchase voucher.
• Cash book (Petty cash expenses)
• Subsidiary records (Depreciation, interest etc.)
Apportionment:
Items of overhead cost which require apportionment have to be spread over two or more
departments or cost centers. Apportionment is to be done on an equitable basis. There is no
single basis for apportioning all the common items of overhead. Suitable basis have to be
selected by correlating the basis selected and the item of overhead.
46
Some items and bases which are used in BPL are as follows:
Items of Overhead Basis of Distribution
Rent, Insurance of Building, Depreciation of Floor Space Occupied

Building.
Electricity Meter reading
Power Machine Hour
Fire Insurance Asset Value
Insurance and Depreciation of Machinery Capital Value
Supervision Number of Workers
Medical Expenses Number of Workers
Canteen Expenses Number of meals
Store-keeping Expenses Number of Requisitions
Fringe benefits Number of workers
Purchase Department expenses Number of Purchase order
Internal Transport Number of Requisitions
Other items Machine hours, Wages.
Absorption of Overhead:
Actual rates: Actual rate is computed by dividing the actual overhead for a particular period by
the selected base. If a month is taken as the period for which the rate is to be computed, and the
basis is the quantity produced during the month, the actual rate is arrived at by dividing the
actual overhead incurred by the units actually produced.
Disadvantages:
• Delay in costing products.

• Involves more clerical work. Actual rates are necessary to be calculated for each
accounting period.
• When production is reduced owing to fall in demand, the actual rate gets inflated.
47
Predetermine rates: Pre- determined rate of absorption is computed at the commencement of
each year. The rate is determined by dividing the estimated or budgeted manufacturing overhead
by the estimated or budgeted output during the year.
Advantages:
• Facilitates casting of products much before production.

• Involves less clerical labor.
• Rates are computed for different departments only once at the beginning of the year.
Disadvantages:
• It gives the problem of under or over absorption.
Example: Suppose; Budgeted annual overhead 48000 and budgeted direct labor for annual
24000.
In that case the predetermined overhead rate is 2 taka per hour. I have calculated this rate by
using the following formula.
Formula= [Budgeted overhead cost for the year / Budgeted direct labor for the year]
Beximco Pharma’s Practice:
In Beximco Pharma they use the pre determined factory overhead. Cost and budget section of
BPL commonly known in BPL as IOC&BP section of Accounts and Finance department
determines the Predetermine overhead rate.
Methods of Overhead Absorption:
The various methods of Overhead absorption are as follows:
• Production unit method.

• Percentage method.
• Hourly rate method.
Beximco Pharma’s Practices:
In BPL they determine their factory overhead rate on the basis of number of batch because
Beximco Pharma uses the Batch costing system. On the basis of the total production of the
48
batches BPL determines the factory overhead per unit and per batches. So we can say that they
use production unit method. At the same time for some costing BPL uses the Percentage method.
They use direct material percentage for many cases. For example in case of new material pricing
they use percentage method. In case of preparing tender cost sheet BPL uses the percentage
method. They also calculate direct labor hour and machine hour and their cost respectively. But
this information is authorized to disclose. In cost of goods sold reporting they don’t disclose
direct labor hour cost because of confidentiality purpose.
Basic Costing systems and Beximco Pharma’s Practices:
The basis of a cost accounting system begins with the type of costs that flow into and through the
inventory accounts. There are three alternatives including: pure historical costing, normal
historical costing and standard costing.
Pure historical costing In a pure historical cost system, only historical costs flow
through the inventory accounts. Historical costs refer to the costs
that have been recorded.
Normal historical costing Normal historical costing uses historical costs for direct material
and direct labor, but overhead is charged, or applied to the
inventory using a predetermined overhead rate per activity
measure.
Standard costing In a standard cost system, all manufacturing costs are applied, or
charged to the inventory using standard or predetermined prices,
and quantities. The differences between the applied costs and the
actual costs are charged to variance accounts.
Cost of Production
In Beximco Pharma, they use normal historical costing for determining cost of production. Also
in some cases they use the standard costing method. They have standard cost sheet for every
components of the manufacturing cost. They also use standard cost sheet for proper control and
measure their performance. They also calculate variance from standard and actual. For doing the
costing early they use predetermined factory overhead. For using normal historical costing
49
systems they determine the over applied or under applied factory overhead and dispose this over
applied or under applied factory overhead through cost of goods sold statement. They also do the
variance analysis. They generally does the Spending variance and Idle capacity variance. They
compare their budgeted and actual amount for calculation of spending variance.
Inventory valuation methods and Beximco Pharma’s Practices:

The major inventory valuation methods are discussed as follows:
The Direct or Variable Method In the direct (or variable) method, only the variable
manufacturing costs are capitalized, or charged to the
inventory.
The Full Absorption Method Full absorption costing (also referred to as full costing
and absorption costing) is a traditional method where all
manufacturing costs are capitalized in the inventory, i.e.,
charged to the inventory and become assets.
The Activity Based Method Activity based costing is a relatively new type of
procedure that can be used as an inventory valuation
method. The technique was developed to provide more
accurate product costs. This improved accuracy is
accomplished by tracing costs to products through
activities. In other words, costs are traced to activities
(activity costing) and then these costs are traced, in a
second stage, to the products that use the activities.
The Throughput Method The throughput method was developed to complement a
concept referred to as the theory of constraints. In this
method only direct material costs are charged to the
inventory. All other costs are expensed during the period.

In BPL they use Absorption costing concept for determining product cost. They charge their
selling and administrative overhead to the income statement. They don’t fully use ABC costing
by they try to apply concept of Activity based costing for determining product cost.
Implementation of ABC is very complex country like Bangladesh. In case of allocating factory
overhead they use concept of ABC as far as possible. BPL don’t use through put costing and
direct costing.
50
Determination of Manufacturing Cost per unit:
In BPL, they determine manufacturing cost per unit through the following cost sheet:
Beximco Pharmaceuticals Ltd.

Product Name: Pack size
Product Code: Date:
Composition Material Per Tablet Per Pack
Code Quantity Cost Quantity Cost
Raw Materials:
Raw material 1
Raw material 2
Total Raw material cost

Packing Material:
Packing material 1
Packing material 2
Total Packing material cost
Total (RM+PM) cost
Total Raw material cost per pack
Total Packing material cost per pack
Total (RM + PM) cost per pack
Factory Overhead
Depreciation
Total Factory Cost
Total Manufacturing Cost Per Pack
Cost of Goods Sold:

Cost of goods sold reporting in BPL is as follows:
Particulars 2010 2009
Work-in-process(Opening) 189396879 171647779
Materials Consumed 2537648743 2259811565
Factory Overhead 894097750 591289797
Work-in-Process (Closing) (195111787) (189396879)
COST OF PRODUCTION 3426031585 2833352262
Finished Goods (Opening) 554393259 358010498
FINISHED GOODS AVAILABLE 3980424844 3191362760
Finished Goods (Closing) (565049644) (554393259)
3415375200 2636969501
Cost of Physician Sample transferred to sample (97734946) (70762875)
stock
3317640254 2566206626
51
List of Factory Overhead:
Particulars 2010 2009

Salary & Allowance 270910357 200123833
Repairs 66680578 57717740
Insurance Premium 10762989 3714356
Municipal tax & land revenue 1237290 1000652
Advertisement & subscription 96769 82295
Registration & Renewal 715777 645612
Travelling 2250371 1302204
Entertainment 721850 481780
Research and development 6815379 4489878
Printing & stationary 5765044 467856
Telephone & Postage 2228125 1943146
Toll Charge 76281942 38534380
Electricity, Gas & Water 40587162 19495457
Training 609919 506787
Plant certification and regulatory approval 12753618
Depreciation 392890096 254668568
Other Expenses 2790484 1904548
894097750 591289797
Inventory:
Inventory Reporting in Beximco Pharma is as follows:

Finished Goods 565049644
Work-in-process 195111787
Raw Materials 769883557
Packing Materials 327253736
Laboratory Chemicals 4076834
Physician Samples 41239901
Raw & Packing Material in Transit 81193985
1983809444
In Beximco Pharma factory overhead is charged in Cost of goods sold and administrative and
selling, marketing and distribution expenses are charged to the income statement as operating
expenses. Beximco Pharma follows the concept of conversion cost and does the reporting of cost
of goods sold on the basis of this. In case of conversion cost direct labor and factory overhead
are merged. In case of reporting inventory they fully apply International Accounting Standard
(IAS) 2. BPL makes compliance with IAS/BAS 2 in case of inventory.
52
Batch costing:
Batch costing is a modification of job costing. A batch of similar products is treated as a job.
Each batch receives an order number and the costs are accumulated on that basis. When
production is of repetitive nature, and consists of a definite number of articles, batch costing is
used. In batch costing all costs are collected according to batch order number and total costs are
divided by total numbers in a batch to arrive at the unit cost of production.
Determination of EBQ:
In batch costing, determination of economic size of the batch is an important step. Economic size
of a batch is determined by applying the following formula:
. .
EBQ =
Where,
A= Annual demand for the product.
S= Setting up cost per batch.
C= Carrying cost per unit of production.
In BPL they use batch costing system. They collect all costs by batch order number. They divide
total costs by total numbers in a batch to arrive at the unit cost of production. IOC&BP section of
Accounts and finance department does the batch costing. This section does not determine the
batch size. Batch size is determined by the Planning department of the BPL. By determining
EBQ they determine economic batch sizes.
Batch Cost Sheet:

Accounts and finance department of BPL determine the batch cost sheet. To determine batch
cost sheet planning department helps costing department giving adequate data. The main factor
of the batch cost sheet is commercial yield. Through this they determine per unit cost.
A sample batch cost sheet is in the following page
53
Batch Cost Sheet
Product Name: Pack Size:
Product Code: Batch Size:
Batch No:
SRR (Store Received Report) Number:
Material Name M. Code Unit (gm/kg) Quantity Rate Value
Raw material 1
Raw material 2
Raw material Cost
Packing Material 1
Packing Material 2
Packing Material Cost
Total Cost (RM + PM)
Per unit RM [ Total RM / Commercial yield]
Per unit PM [ Total PM / Commercial yield]
Per unit Total Cost (RM+PM) [(RM+PM)/ Commercial yield]
Standard Yield: Commercial Yield:

Actual Yield: QC Sample:
54
3.2.4 Contemporary cost accounting methods and techniques used by
Beximco Pharma:
Total quality management:
Total Quality Management refers (TQM) to the process of continuous improvement to achieve
the full customer satisfaction. Rather than waiting to inspect items at the end of the production
line or striving to stay within acceptable tolerance limit, TQM’s goal is eliminating all waste. In
Beximco Pharma, quality is maintained with great care. As it is a pharmaceutical company, it is
mandatory to keep up with the quality level with the other companies. As a result, they have
received GMP Clearance from Therapeutic Goods Administration (TGA) of Australia and from
Gulf Central Committee for Drug Registration, Executive Board of the Health Ministers' Council
for Gulf Cooperation Council (GCC) states (representing Saudi Arabia, Kuwait, Bahrain, United
Arab Emirates, Qatar and Oman). The company is also in the process of obtaining approvals
from several other regulatory authorities including National Health Surveillance Agency
(ANVISA) of Brazil, Medicine and Healthcare Regulatory Agency of United Kingdom (UK
MHRA), US FDA etc.
Life Cycle Costing:
Life cycle costing tracks and determines the cost attributed to each product and service from its
initial research and development to development to final marketing to customer. In Beximco
Pharma , as I discussed that this type activities is done in mainly in the Strategic Brand
Management (SBM) Department. The activities of SBM are:
Market research
Selection of new product
Design and testing of product (DTP)
Sample store (logistics) management
Making strategy
With the SBM departments, Beximco Pharma determines the Life Cycle of the products.
55
Target Costing:
Target costing is an approach which determines what a product or service should cost based on
its sales price less a target profit. Basically, it is a tool for decision making. Unlike traditional
costing for making up cost, it is a market driven way of examining the relationship of price and
cost. In Beximco Pharma, the use of Target Costing is very common to make the target for the
cost of the product.
Activity-Based Costing
Activity-based costing (ABC) developed to provide more accurate ways of assigning the costs
of indirect and support resources to activities, business processes, products, services, and
customers(Kaplan and Atkinson, 2001:97). Activity-based costing is a method of assigning costs
that calculates a more accurate product cost by identifying all of an organization’s major
operating activities. The goal of ABC is not to allocate common costs to products but to measure
and then price out all the resources used for activities that support the production and delivery of
products and services to customers. For this why, ABC is important to activity-based
management. In Beximco pharma, although the ABC system is not fully implemented, still it
tries to follow the methods of this innovative costing process along with the Standard costing.
Just because, the y found many major cost drivers in case of manufacturing the goods, which
needs a careful attention to determine manufacturing overhead. Some of the examples of such
cost drivers are as follows;
• Research And Development Cost • Number Of Batch
• Direct Labour • Batch Size
• Labour Hour • Process Of Production
• Types Of Product
56
3.2.5 Factors That Affects The Costing Procedure At Beximco Pharma
The Major reasons for which the price of the materials affected are identified below:
LC opening charge: The LC opening charge increases with the amount of LC opened. It will
affect the actual price of the materials.
Insurance premium: For the safety of the materials it is necessary to give insurance premium
for that material. Numbers of insurance companies are interest to open insurance for the
firm. But this also affects the material price.
Demurrage charge: It has to be given to the port authority by the BPL in case of
delaying in material receive.
Inflation: Due to inflation rate material price can also be increased which has impact on
purchasing of materials. The company would have nothing to do if there is occurred high
inflation in the imported country.
Exchange rate changes: material price can also be affected by the exchange rates
changes. In spite of, the unchanged material price the cost of it can be increased by the change
in foreign exchange rates.
C & F commissions: Clearing and forward commissions are charged by the agents which
are works for the Beximco. There are number of agents who receive the goods, pay all types
of duty charges to the government and bring the materials to the factory storehouse. The C & F
commissions include:
• Documentation • Cooly wages for loading and
• Customs duty and taxes unloading
• Super urgent delivery expenses • Transport
• Wharf rent and removal • Agency commission
• Pay order commissions
All the above items of C & F commissions are added with the cost of the material.
Therefore the actual price of the material is increased.
57
Miscellaneous expenses: Besides the above factors some other costs are incurred in
case of material import. These costs are also included with the material price.
Exchange Rate: Basically, 70-80 percent materials are purchased from outside of the
country. So payments for the imported goods are made in dollars maximum time. So
the increase in the exchange rate would increase the prices of the materials. According to
the survey data the, it was found that 66 percent employee that that the exchange rates
affects moderately and 33 percent employee thought that the exchange rates has less
effects. The reason behind such opinions was that for the last numbers of months
dollar is stable against taka. Furthermore, the payment was made in dollar maximum
time. Another thing was the exchange exercised by the customs was almost fixed for
number of months. So, when the exchange rates changes abruptly only then there would
be a high impact over price of the materials.
Yearly increment of salary: This is one of the major issues of labor rate increasing.
Beximco Pharma provides salary increment every year. Therefore, the cost of direct
labor is increased.
Increase in market labor rate: This is due to inflation rate of a country. The
market rate of labor payment has been increasing for last two or three years. So, this
has also a great impact on direct labor cost.
Other benefits of the labor: Besides the monthly payments, the labors are
provided some other benefits which also affect the costing. At Beximco factory, there
are labor unions which deal with the management about their needs and benefits.
The reasons for increasing the overhead cost are-

• Markets rates of utilities like gas,
• electricity and water,
• Repair and the maintenance costs,
• Insurance premiums etc. are increased due to reducing the life of the machines.
58
CHAPTER FOUR: FINDINGS
Working on the costing procedure of Beximco Pharmaceuticals Limited was an
interesting issue. The following findings are made on the basis of research work:
• The employees of departments of Beximco Pharma are very much co-operative
and interdependent to each other.
• The cycle or chain of performing all functions is very well-organized.
• Beximco Pharma uses conversion cost concept for reporting cost of goods sold
and preparing cost sheet.
• Beximco Pharma follows the batch costing method and collocate their factory
overhead on the basis of the total production of the batches.
• Beximco Pharma uses pre determined factory overhead for determining factory
overhead early for costing purpose.
• Beximco Pharma does the variance analysis comparing actual and budgeted
amount.
• Beximco Pharma tries to control overhead through the budgetary control.
• Beximco Pharma also prepares cost report for managerial purpose.
• They use standard cost sheet for measuring their performance properly.
• Beximco Pharma doesn’t fully apply Activity based costing but they try to use
the concept of ABC in allocating overhead.
• Beximco Pharma follows the absorption costing method to prepare cost sheet.
• Major reasons for which the price of the materials is affected are-LC opening
charge, Demurrage charge, Inflation, Exchange rate changes and C&F
commissions, etc.
• Yearly increment of salary is one of the major issues of labor rate increasing.
Beximco Pharma provides salary increment every year. Therefore, the cost of
direct labor is increased.
• The reasons for increasing the overhead cost are- Markets rates of utilities like
gas, electricity and water, Repair and the maintenance costs, Insurance
premiums etc. are increased due to reducing the life of the machines.
59
CHAPTER FIVE: RECOMMENDATION
Beximco Pharma tries to ensure better quality and better management. The staffs
demonstrate their knowledge and experience with sheer professionalism. Despite these
efforts some shortcomings may remain and there is always an opportunity to overcome
those. Trough out my study I have found that they have some opportunity that they can
take being taking proper steps. On the basis of my understanding and observation I am
proposing the following recommendation to the Beximco Pharma:
Cost of Goods Sold:

Beximco Pharma may improve their Cost of Goods sold reporting for better
understanding. Though it is not contradictory with the IAS/BAS. To make user friendly
BPL may change this format.
Beximco Practices Proposed Format

Work in process (opening) Raw material consumed
(+) Material consumed (+) Packing material consumed
(+) Factory overhead MATERIAL CONSUMED
(-) Work in process (closing) (+) Work in process (opening)
COST OF PRODUCTION (-) Work in process (closing)
(+) Finished goods (opening) TOTAL CONSUMPTION
FINISHED GOODS AVAILABLE (+) Factory Overhead
(-) Finished goods (closing) COST OF PRODUCTION
(-) Cost of physician sample (+)Purchase of Finished goods
COST OF GOOD SOLD (+)Finished goods (opening)
(-)Finished goods (closing)
(-)Cost of physician sample
COST OF GOOD SOLD
Factory Overhead, Selling and Administrative overhead:

Factory overhead, selling and administrative overhead is increasing year to year. The
increasing trend is totally straight. Company should control the overhead properly. We
know that company has no direct control over raw material prices. In the increasing raw
material every company will be sufferer but company can properly control the overhead.
The control of overhead is totally under the decision of the management. Management
should proper analysis of the overhead cost on the basis of this analysis they should
60
prepare budget. Company should not prepare the budget on the basis of the requirement
of the department demand. Cost manager should have proper knowledge about the all
departments’ functions and activities properly.
Petty Cash Expenses:

Beximco distributes their goods through I & I services. I &I services gets commission for
their activities. I&I service takes their expenses from daily cash collection for expenses of
distribution.
With the working with the petty cash section I have shown that depot of the I&I services
overstate their expenses. For these activities the overhead cost is increasing day by day.
Proposed Policy: Beximco Pharma should make budget for the daily expenses. Through
proper budgetary control and research on that will minimize the expenses. BPL should set
out daily allowance of the depot of I&I services on the basis of the proper study and
observation.
Negotiation with the Insurance Company:

In Beximco Pharma there are many insurance companies. BPL always does insurance of
their material. The management should negotiate with them to reduce their insurance
premium charges. One or two company will be allowed to do all kinds of insurance.
Through this negotiation BPL will be able to reduce the expenses.
Expansion of the Shuktara Printers, BAIL, Prarmateck and I&I services:

Shuktara Printers is the supplier of the printing and packaging materials of the BPL.
Shuktara printer is the related party of the BPL but they are not able to supply all the
printing and packing materials. BPL has to purchase printing materials from other
sources. If BPL is able to manage all packing and printing materials from Shuktara then
will be cost effective. If possible Shuktara will be able to sell other company for surplus.
For BAIL, Pharmateck and I&I services, I also recommend expansion policy in the same
way. May these company will be leading company in the respective field like BPL, If
management takes the appropriate decision.
61
CONCLUSION
Beximco Pharmaceuticals Ltd. is a leading edge pharmaceutical company and is a
member of the BEXIMCO Group, the largest private sector industrial conglomerate in
Bangladesh. Beximco Pharma is also the largest exporter of pharmaceuticals from
Bangladesh, spreading its presence in many developing and developed countries across
the globe. Recently, BPL has successfully made its footmark in the global market when it
made its debut on the London Stock Exchange as the first Bangladeshi company to be
listed in the world's most prestigious bourse. This milestone event has widened the
responsibility, accountability and transparency of the company beyond geographical
border. This was an added challenge to all the accounting staffs as the listing the
accountability of the organization has gained a global reach. The ever expanding export
trade also indicates greater responsibility to the world. The Finance and Accounts
department took the challenge and prove their mettle by the timely publication of 2005
Annual Financial Reports globally. Each and every section in the department deserves to
be complemented for their endeavor. From raw material import to the bringing of smile
for the society, on every level, professionalism and dedication is the key to this success.
In this report, we have tried my level best to identify management accounting

techniques and procedures used by Beximco Pharma. What and how Beximco Pharma
use cost accounting information for decision making and external financial reporting
along with describing the procedure and systems of using cost accounting information. In
this report, we imply our acquired knowledge from cost accounting course and try to
comply with the techniques procedure and systems followed by the company.
In today's complex yet highly competitive business environment management needs

quality information for decision making purpose. Beximco believes that quality and
control should be ensured and these can be ensured by using proper cost accounting
information. Relevant and reliable cost information can be ensured by implementing by
using effective cost accounting methods. And they do the best one fit in the context of
Bangladesh.
62
Bibliography:
Books:
1. Managerial Accounting
Ray H. Garrison
Eric W. Noreen
2. Intermediate Accounting
Kieso, Weygandt, Warfield
10th Edition
3.“Cost Accounting: A Managerial Approach”,

Prentice Hall, Inc.; 12th Edition, 2007.
4. “International Financial Reporting Standard”;

International Accounting Standard Board; as approved at 1 January, 2008.
Websites:
http://www.beximco-pharma.com
http://financenmoney.wordpress.com/2011/02/07/differences-between-financial-
accounting-management-accounting-and-cost-accounting/
dspace.bracu.ac.bd/bitstream/10361/580/1/vol%203%20No.%202.13.pdf
http://en.wikipedia.org
http://www.iasplus.com
Previous Internship Report.
63

Internship Report On Management Accounting Practice at Beximco Pharmaceuticals LTD: A Review of Costing Function

Uploaded by

Copyright:

Available Formats

Internship Report On Management Accounting Practice at Beximco Pharmaceuticals LTD: A Review of Costing Function

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Internship Report On Management Accounting Practice at Beximco Pharmaceuticals LTD: A Review of Costing Function

Uploaded by

Copyright:

Available Formats

Internship Report

Syeda Afrina Sarwar

BRAC University, Bangladesh

Syeda Afrina Sarwar

Subject: Submission of Internship Report

Syeda Afrina Sarwar

Beximco is part of the Beximco Group of Companies. The history of pharmaceutical

CHAPTER ONE: INTRODUCTION

1.1 Origin of the report:

1.2 Objective of the report:

• To have an idea about the background of Beximco pharmaceuticals Ltd.

• To explore the specific costing procedure followed by the Beximco

1.3 Scope of the report:

1.4 Methodology of the report:

Data regarding the organization profile collected in the following ways:

7 Organizational Brochures/ Annual Reports.

Data Collection Techniques:

1.5 Organization of the study

CHAPTER TWO: PART ONE-

2.1.1 Historical background:

Beximco Pharmaceutical Ltd. is a leading edge pharmaceutical company based in Dhaka,

2.1.4 Organizational Structure of BPL

2.1.5 Board and Management

The Board of Directors:-

Iqbal Ahmed Director

Rabbur Reza Director, Marketing

In 2010 Beximco Pharma introduced 27 new generics in a total of 34 presentations, which

Block Buster product:

Napa Highest selling drug in Bangladesh

2.1.7 International Market:

Research & Development:

2.1.9 Corporate Social responsibility:

Corporate social responsibility (CSR), also known as corporate responsibility, corporate

Corporate Social Responsibility (CSR) is an integral part of Beximco Pharmaceuticals business

CHAPTER TWO: PART TWO-

2.2 Departments of Beximco Pharma

• Project management & Business Development Department

2.2.1 Brief Description of Accounts & Finance department and others.

Hierarchy of Accounts and Finance Department:

Financial Financial Treasury Legal Tax and Pay IOC&BP

Accounts Accounts Accounts Accounts Accounts

Asst. Asst. Asst. Asst. Asst. Asst.

Financial Accounts SBU:

Financial Accounts Non SBU:

Tax and Payroll:

2.2.2 Brief description of others departments:

Strategic Brand Management (SBM) Department

Planning & Inventory Control Department

Sales department is a marketing execution department. It supplies sales forecast to the

Human Resource Department

Major Activities of HR departments are as follows:

• Prepare Recruitment policy and procedure

Project management & Business Development Department

• New product study

• New technology study

• Project feasibility study

Functions of the multimedia department are:

CHAPTER THREE: PART ONE-

3.1.1 Definition of Management Accounting